|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Wang Y and Li G: ING3 promotes UV-induced
apoptosis via Fas/caspase-8 pathway in melanoma cells. J Biol Chem.
281:11887–11893. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moreno A, Palacios A, Orgaz JL, Jimenez B,
Blanco FJ and Palmero I: Functional impact of cancer-associated
mutations in the tumor suppressor protein ING4. Carcinogenesis.
31:1932–1938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li J and Li G: Cell cycle regulator ING4
is a suppressor of melanoma angiogenesis that is regulated by the
metastasis suppressor BRMS1. Cancer Res. 70:10445–10453. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie Y, Sheng W, Miao J, Xiang J and Yang
J: Enhanced antitumor activity by combining an adenovirus harboring
ING4 with cisplatin for hepatocarcinoma cells. Cancer Gene Ther.
18:176–188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Garkavtsev I and Riabowol K: Extension of
the replicative life span of human diploid fibroblasts by
inhibition of the p33ING1 candidate tumor suppressor. Mol Cell
Biol. 17:2014–2019. 1997.PubMed/NCBI
|
|
7
|
Shiseki M, Nagashima M, Pedeux RM,
Kitahama-Shiseki M, Miura K, Okamura S, Onogi H, Higashimoto Y,
Appella E, Yokota J and Harris CC: p29ING4 and p28ING5 bind to p53
and p300, and enhance p53 activity. Cancer Res. 63:2373–2378.
2003.PubMed/NCBI
|
|
8
|
Garkavtsev I, Kozin SV, Chernova O, Xu L,
Winkler F, Brown E, Barnett GH and Jain RK: The candidate tumour
suppressor protein ING4 regulates brain tumour growth and
angiogenesis. Nature. 428:328–332. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi X, Hong T, Walter KL, Ewalt M,
Michishita E, Hung T, Carney D, Peña P, Lan F, Kaadige MR, et al:
ING2 PHD domain links histone H3 lysine 4 methylation to active
gene repression. Nature. 442:96–99. 2006.PubMed/NCBI
|
|
10
|
Cai L, Li X, Zheng S, Wang Y, Wang Y, Li
H, Yang J and Sun J: Inhibitor of growth 4 is involved in
melanomagenesis and induces growth suppression and apoptosis in
melanoma cell line M14. Melanoma Res. 19:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hassler M, Seidl S, Fazeny-Doerner B,
Preusser M, Hainfellner J, Rössler K, Prayer D and Marosi C:
Diversity of cytogenetic and pathohistologic profiles in
glioblastoma. Cancer Genet Cytogenet. 166:46–55. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li J, Martinka M and Li G: Role of ING4 in
human melanoma cell migration, invasion and patient survival.
Carcinogenesis. 29:1373–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gunduz M, Nagatsuka H, Demircan K, Gunduz
E, Cengiz B, Ouchida M, Tsujigiwa H, Yamachika E, Fukushima K,
Beder L, et al: Frequent deletion and down-regulation of ING4, a
candidate tumor suppressor gene at 12p13, in head and neck squamous
cell carcinomas. Gene. 356:109–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang X, Xu LS, Wang ZQ, Wang KS, Li N,
Cheng ZH, Huang SZ, Wei DZ and Han ZG: ING4 induces G2/M cell cycle
arrest and enhances the chemosensitivity to DNA-damage agents in
HepG2 cells. FEBS Lett. 570:7–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tapia C, Zlobec I, Schneider S, Kilic E,
Güth U, Bubendorf L and Kim S: Deletion of the inhibitor of growth
4 (ING4) tumor suppressor gene is prevalent in human epidermal
growth factor 2 (HER2)-positive breast cancer. Hum Pathol.
42:983–990. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Soliman MA and Riabowol K: After a decade
of study-ING, a PHD for a versatile family of proteins. Trends
Biochem Sci. 32:509–519. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Radhakrishnan SK, Feliciano CS, Najmabadi
F, Haegebarth A, Kandel ES, Tyner AL and Gartel AL: Constitutive
expression of E2F-1 leads to p21-dependent cell cycle arrest in S
phase of the cell cycle. Oncogene. 23:4173–4176. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Niculescu AB III, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21 (Cip1/Waf1) at both the
G1/S and the G2/M cell cycle transitions: pRb is a critical
determinant in blocking DNA replication and in preventing
endoreduplication. Mol Cell Biol. 18:629–643. 1998.PubMed/NCBI
|
|
19
|
Pierrat B, Simonen M, Cueto M, Mestan J,
Ferrigno P and Heim J: SH3GLB, a new endophilin-related protein
family featuring an SH3 domain. Genomics. 71:222–234. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weng C, Li Y, Xu D, Shi Y and Tang H:
Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
in Jurkat leukemia T cells. J Biol Chem. 280:10491–10500. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Cowan-Jacob SW, Simonen M,
Greenhalf W, Heim J and Meyhack B: Structural basis of BFL-1 for
its interaction with BAX and its anti-apoptotic action in mammalian
and yeast cells. J Biol Chem. 275:11092–11099. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tzouvelekis A, Aidinis V, Harokopos V,
Karameris A, Zacharis G, Mikroulis D, Konstantinou F, Steiropoulos
P, Sotiriou I, Froudarakis M, et al: Down-regulation of the
inhibitor of growth family member 4 (ING4) in different forms of
pulmonary fibrosis. Respir Res. 10:142009. View Article : Google Scholar : PubMed/NCBI
|
